15/07/2025 - Campus Can Ruti, Research

The Ibero-American network RIGHT PLUS, coordinated from the Can Ruti Campus, launches LAMIS 2025, a key study on the health of gay, bisexual and other men who have sex with men in Latin America and the Caribbean

The second edition of the LAMIS survey is being coordinated from the Can Ruti Campus. This key international study explores the psycho-socio-sexual health of gay, bisexual and other MSM across 24 countries in Latin America and the Caribbean, with active involvement of the CEEISCAT research group.

09/07/2025 - Campus Can Ruti, Projects, Success Stories

Fundación Mutua funds a Can Ruti project on the role of unknown viruses in head and neck tumours

Research teams from IGTP, ICO and IrsiCaixa have been granted funding from Fundación Mutua Madrileña to conduct the ERICA Project, which aims to investigate the role of viral infections in the development of squamous cell carcinoma of the head and neck.

09/07/2025 - Campus Can Ruti, Research

Women more susceptible to certain subjective effects of alcohol during binge drinking episodes

A study led by IGTP and HUGTiP finds that women feel stronger effects from binge drinking, even at equal blood alcohol levels. The research also warns that mixing alcohol with energy drinks does not reduce impairment and may encourage risky behaviour.

01/07/2025 - Campus Can Ruti, Research

Study highlights opportunities to strengthen early HIV diagnosis in primary care in Catalonia

The results of a study published in EuroSurveillance highlight biases and inequalities based on sex, age, origin and region, and point to the need for training, clear protocols and alert systems to improve early diagnosis. The study was led by researchers from CEEISCAT, IDIAPJGol and IGTP.

25/06/2025 - Campus Can Ruti, Research

An international study validates the efficacy of a drug in adults with neurofibromatosis type 1

An international study, published in The Lancet, demonstrates for the first time that the drug selumetinib is effective in reducing tumours and associated pain in adults with neurofibromatosis type 1 (NF1). IGTP and Hospital played a key role in the clinical trial, which marks a significant advance in the treatment options for this rare genetic disease.

19/06/2025 - Campus Can Ruti, Conferences, Innovation, Success Stories

The Innomed Awards highlight fifteen innovative biomedical projects in their second edition

The Innomed program, an initiative led and coordinated by the IGTP, has concluded the second edition of its GrowInn project incubator with the celebration of the Innomed Awards, which have gathered over 150 people and recognised five projects for their talent and determination.

12/06/2025 - Campus Can Ruti, Conferences, Research, Success Stories

Successful turnout at the 1st CORE IGTP Scientific Conference, a meeting to advance population health research

The first CORE IGTP Scientific Conference was held at the Badalona International Business Centre (BCIN), an initiative of the CORE Program that aims to establish itself as an annual space for meeting, debate and scientific exchange among professionals involved in population health research.

11/06/2025 - Campus Can Ruti, Research

New research explores the potential of empagliflozin and sacubitril/valsartan as early treatment after a myocardial infarction

Researchers from ICREC-IGTP have conducted a preclinical study on the effects of the drug empagliflozin, alone or in combination with sacubitril/valsartan, in the early phase following a myocardial infarction. The combination of the two showed promising results.

10/06/2025 - Campus Can Ruti, Research, Success Stories

Study led by IGTP reveals correlation between tuberculosis lesion transcriptomics and patients’ clinical parameters

Researchers from the Experimental Tuberculosis Unit (UTE) at the IGTP and the Germans Trias i Pujol University Hospital have published a study in Nature Communications in which, for the first time, the transcriptomic profile of human tuberculosis lung lesions is correlated with clinical data from the same patients.

04/06/2025 - Campus Can Ruti, Innovation, Projects

IGTP involved in three European innovation projects receiving over 12 million euros in funding

The IGTP, through the INEDIT group, is involved in three major European projects committed to health innovation, with over €12 million in funding.